Androgens are hormones that have a male influence on the body. Excess androgens in a woman's body is an unbearable complaint. This is manifested in various ways, mainly as pimples, usually called pimples. Other forms of hyperinfection in women include a predisposition to oily skin or seborrhea and excessive hair growth in undesirable parts of the body, such as limbs or the face, called hirsutism. It is also known that polycystic ovaries in many women are associated with an excess of androgens. Ginette 35 emits a beam of light in this spectrum of androgen-excessive disorders. Ginette 35 very effectively suppresses the hyperinfected state, and when used for a certain period of time, relieves these diseases. Despite the fact that Ginette 35 is sold as a medicine for this purpose, it provides an additional contraceptive bonus to selected women.
Ginette-35 birth control pills contain 0.035 mg of ethinylestradiol and 2 mg of cyproterone acetate. Unique to Ginette 35 is the presence of cyproterone acetate. This agent is a special type of progestin, which has an anti-androgenic or male hormonal effect. Ethinyl estradiol, on the other hand, is the most common form of estrogen in combination hormonal or contraceptive pills. Offering an ethinylestradiol dose in Ginette 35 is a low dose that reduces estrogenic side effects while at the same time maintaining strong additional or indirect anti-androgenic activity.
Ginette 35 for the treatment of acne/ acne: Ginette 35 reduces the appearance of oily skin on the face. Reduced skin secretion easily escapes from the glands and blocks their holes. This action is vital in reducing the blossoming and spread of acne. In addition, the inflammation from such oil excreta is reduced and the gland holes are patented enough to facilitate the outflow of sebum. The best effect of Ginette 35 is to be used for 3-4 months, resulting in a gradual decrease in the severity of pimples. Ginette 35 for the treatment of oily skin / seborrhea: Testosterone and other similar male hormones, also known as androgens, are present in women in small quantities. They increase the tendency of the skin to oily secretions of the sebaceous gland and accompanying problems such as acne, peeling, boils and subsequent infections. Seborrheic secretions are very well controlled by the constant use of Diane 35 birth control pills. There is a consistent reduction in skin fatness due to controlled secretion of sebum, especially sebaceous facial glands and other hairy areas. Unwanted hair growth / idiopathic hirsutism: Excessive hair growth is also a result of the increased action of androgens in a woman's body. The underlying causes of severe male hormone action are diverse and should be treated as soon as possible (e.g. a tumour producing androgens). However, there is the essence of "idiopathic hirsutism", in which the body of the affected woman for unknown or unexplained reasons is simply more sensitive to androgenic hormonal effects. This subclass of hirsute women benefits most from the treatment of Ginette 35. Ginette 35 for the treatment of polycystic ovaries (PCOS): PCOS is characterized by numerous tiny follicular cysts in the ovaries. In addition, other disorders characteristic of this syndrome include long menstrual cycles, increased testosterone / androgen activity, tendency to excessive hair growth, dark skin pigmentation, oily predisposition and infertility. Ginette 35, produced by Cipla, provides treatment in women with polycystic ovarian syndrome at various levels, helping to normalize their menstrual cycle, reduce acne, control seborrhea and hair growth and, above all, contribute to fertility in these women after discontinuing their intake. So far on Ginette 35, contraception is always an extra bonus.
If the Ginette 35 birth control pills have already been used in some other birth control pills, they are best started the day after the last active pill from the previous package has been taken or at least the day after the last active pill from the previous package has been taken. For the first time, users who have been prescribed Ginette 35 for any of the designated indications should start on the first day of menstruation, and 21 active tablets should be taken once a day, without missing between them. The "Bleeding removal" occurs approximately three to four days after the end of the package. This is a medically induced bleeding or an artificial period. This simulates the natural period only in time, but ovulation has not occurred. The transition to Ginette 35 from other progestogen-based contraceptives is as follows In the case of vaginal contraceptives, the Ginette 35 contraceptive pill is used on the day the ring is removed. The Minipill or implant or the Ginette 35 IUD/system can be started at any time, but additional barrier protection (condom/diaphragm) must be used during the first 7 days. The Ginette 35 contraceptive is effective 7 days after the first package has been used. A decrease in the activity of Ginette 35 was noted with barbiturates, primiidone, carbamazepine, rifampicin, oxcarbazepine, topiramate, felbamate, griseofulvin, products containing St. John's wort, ritonavir and nevirapine. Therefore, women are advised to use additional barrier contraception when taking any of these drugs. Laboratory results, which may be affected by Ginette 35, include liver function tests, thyroid profiles, coagulation studies, kidney function, blood diabetes/glucose parameters and blood lipid profiles.